Lazard Asset Management
CTSO icon

Lazard Asset Management’s Cytosorbents Corp CTSO Stock Holding History

Lazard Asset Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-954
Closed – – 2333
2025
Q1 		$0 Buy
+954
New +$1K ﹤0.01% 2352
2024
Q2 		– Sell
-1,090
Closed -$1K – 2266
2024
Q1 		$1K Buy
1,090
+152
+16% +$148 ﹤0.01% 1959
2023
Q4 		$1K Buy
+938
New +$1.39K ﹤0.01% 2194
2021
Q4 		– Sell
-5,371
Closed -$43K – 2313
2021
Q3 		$43K Buy
5,371
+4,359
+431% +$35.4K ﹤0.01% 1746
2021
Q2 		$7K Sell
1,012
-3,817
-79% -$32.2K ﹤0.01% 1906
2021
Q1 		$41K Hold
4,829
– – ﹤0.01% 1525
2020
Q4 		$38K Buy
+4,829
New +$40.4K ﹤0.01% 1478

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's CTSO Position: Q2 2025 in Review

Lazard Asset Management sold out of Cytosorbents Corp (CTSO) in Q2 2025, closing a stake of 954 shares.

Lazard Asset Management first reported a position in CTSO in Q4 2020 and held it in 7 quarters. The position peaked at $43K in Q3 2021. 45 funds tracked by Wall St. Rank hold CTSO as of Q2 2025.

  • Lazard Asset Management reported no remaining Cytosorbents Corp position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 954 Cytosorbents Corp shares in Q2 2025.
  • Lazard Asset Management first reported a position in Cytosorbents Corp in Q4 2020 and held it in 7 quarters.
  • Lazard Asset Management's Cytosorbents Corp position peaked at $43K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.